E6-19081. Paperwork Reduction Act; Proposed Collection; Comment Request  

  • Start Preamble

    AGENCY:

    Office of National Drug Control Policy.

    ACTION:

    60 day notice.

    SUMMARY:

    The Office of National Drug Control Policy (ONDCP) intends to submit the following information collection request to the Office of Management and Budget for review and approval. ONDCP seeks public comment.

    Abstract: ONDCP will conduct face-to-face interviews and acquire urine samples from booked arrestees to obtain information concerning drug use; drug and alcohol treatment; and, drug market participation and arrests. The use and manufacture of methamphetamines are of particular interest. Participation is voluntary.Start Printed Page 66198

    Type of Information Collection: New collection.

    Title: Arrestee Drug Abuse Monitoring (ADAM II) Program Questionnaire.

    Affected Public: Persons arrested and booked in one of 10 pre-selected booking facilities in the United States in one of two, 2-week data collection cycles spanning six months.

    Estimated Burden: ADAM II proposes 10 sites that each conduct two cycles of surveys from 250 arrestees per cycle. The total number of participants is 5000. The average survey estimate is 20 minutes. Total burden estimate is 1667 hours.

    Goals: ONDCP intends to obtain drug-use data that is directly comparable to data collected under the 2000-2003 National Institute of Justice sponsored Arrestee Drug Abuse Monitoring program; provide consistent data collection points to support statistical trend analysis for the use of heroin, cocaine, crack, marijuana and methamphetamine; monitor the spread or emergence of methamphetamine use; and, support ONDCP's efforts to estimate chronic drug use and examine drug market behaviors.

    Comment Request: Public comments should address whether the proposed data is proper for the functions of the agency; whether the information will have practical utility; the accuracy of ONDCP's estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions; the quality, utility, and clarity of the information to be collected; and, the burden on proposed respondents, including the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, such as electronic submission of responses. Comments will be accepted for sixty days.

    Start Further Info

    FOR FURTHER INFORMATION CONTACT:

    Robert Cohen, ONDCP, Office of Planning and Budget, 750 17th Street #534, Washington DC 20503; telephone (202) 395-5598; facsimile (202) 395-5571.

    Start Signature

    Dated: November 7, 2006.

    Daniel R. Petersen,

    Assistant General Counsel.

    End Signature End Further Info End Preamble

    [FR Doc. E6-19081 Filed 11-9-06; 8:45 am]

    BILLING CODE 3180-02-P

Document Information

Comments Received:
0 Comments
Published:
11/13/2006
Department:
Office of National Drug Control Policy
Entry Type:
Notice
Action:
60 day notice.
Document Number:
E6-19081
Pages:
66197-66198 (2 pages)
PDF File:
e6-19081.pdf